©The Author(s) 2026.
World J Gastrointest Endosc. Jan 16, 2026; 18(1): 112943
Published online Jan 16, 2026. doi: 10.4253/wjge.v18.i1.112943
Published online Jan 16, 2026. doi: 10.4253/wjge.v18.i1.112943
Table 3 Clinical and demographic characteristics, n (%)
| LVP (n = 55) | HVP (n = 12) | P value | |
| Age (years)1 | 35.7 (19.3-90.1) | 34.2 (23-58.4) | 0.423 |
| Male sex | 22 (40.0) | 6 (50.0) | 0.538 |
| Any GI surgery | 5 (9.1) | 1 (8.3) | 1.000 |
| BMI (kg/m2)1 | 24.8 (18.2-37) | 23.6 (15.9-24.9) | 0.235 |
| Smoking | |||
| Never | 21 (56.8) | 10 (90.9) | 0.095 |
| Current | 7 (18.9) | 1 (9.1) | |
| Past | 9 (24.3) | 0 (0.0) | |
| Medications associated with bowel ulcers | |||
| NSAIDS | 2 (3.6) | 0 (0.0) | 0.502 |
| Micropirin | 3 (5.5) | 0 (0.0) | 0.408 |
- Citation: Livne S, Cohen NA, Fliss-Isakov N, Leshno M, Maharshak N, Niv E, Deutsch L. Low-volume bowel preparation provides safe and effective pan-enteric capsule endoscopy in suspected or established Crohn’s disease. World J Gastrointest Endosc 2026; 18(1): 112943
- URL: https://www.wjgnet.com/1948-5190/full/v18/i1/112943.htm
- DOI: https://dx.doi.org/10.4253/wjge.v18.i1.112943